RxDoctor Payments Data

Jaime Evanshine

Women's Health · New Vienna, OHNPI 1346678760

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.9% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $620 and has fallen 92.7% since, to $45 in 2025. Among women's health clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,021in general payments, 2019–2025

Across 113 payments — averaging $17.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$311
  • Exeltis, USA Inc.$294
  • Sumitomo Pharma America, Inc.$265
  • Mayne Pharma Commercial LLC$249
  • Astellas Pharma US Inc$204
  • Agile Therapeutics, Inc.$149
  • plus $549 from 15 others

What the payments were for

  • Food & beverage$1,96097%
  • Education$623%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,021 in reported general payments places this provider in the 90th percentile of 333 women's health providers in Ohio.

See all women's health providers in Ohio

Medicare billing

Part B allowed, 2024
$6,486
Medicare patients
86
Services billed
213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol35$1,843
Oxybutynin Chloride21$320
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip24$258
Medroxyprogesterone Acetate22$228
Alendronate Sodium13$123
Acyclovir13$66
Fluconazole13$47

Paid to pharmacies, not to this prescriber.

Other women's health in New Vienna

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →